Researchers from Fox Chase Cancer Center Discuss Findings in Colon Cancer (Biweekly Dosing of Trifluridine-tipiracil Reduces Rates of Myelosuppression While Maintaining Efficacy In Patients With Metastatic Colorectal Cancer)

Media coverage

• Title	Researchers from Fox Chase Cancer Center Discuss Findings in Colon Cancer (Biweekly Dosing of Trifluridine-tipiracil Reduces Rates of Myelosuppression While Maintaining Efficacy In Patients With Metastatic Colorectal Cancer)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	06/19/25
  Persons	Christopher G. Cann